C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2002
11/14/2002	CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	CA2445271A1 Use of castanospermine esters to treat flaviviridae-related diseases
11/13/2002	EP1256583A1 Pyrimidine-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
11/13/2002	EP1256582A1 1h-imidazopyridine derivatives
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002	EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002	EP1112272B1 Muscarinic agonists and antagonists
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/12/2002	US6479512 Tyrosine kinase inhibitors
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479506 Triazolo-pyridine derivatives as ligands for GABA receptors
11/12/2002	US6479503 Cycloalkano-indole and -azaindole derivatives
11/12/2002	US6479501 Cognition activators; antidepressants
11/12/2002	US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/12/2002	US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002	CA2099591C 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002088124A2 Pyrazolo'1,5-a!pyridine derivatives
11/07/2002	WO2002088123A1 Chemical compounds
11/07/2002	WO2002088122A1 Heterocyclic compounds
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088087A1 Novel heterocyclic derivatives
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002087589A1 Medicine for inhibiting drug elimination pump
11/07/2002	WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	WO2002087575A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
11/07/2002	WO2002087574A2 Use of pyridoindolone derivatives for preparing anticancer medicines
11/07/2002	WO2002087573A1 Crf receptor antagonists
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165392 Method of preparing alkaloids using supercritical fluids from plants
11/07/2002	US20020165391 Novel spiro compounds
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	US20020165238 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants
11/07/2002	US20020165234 Selective B3 adrenergic agonists
11/07/2002	US20020165229 Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases
11/07/2002	US20020165094 Herbicidal synergistic composition, and method of controlling weeds
11/07/2002	US20020164498 Novel compound for red organic electroluminescent elements and devices
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	CA2665516A1 Drug efflux pump inhibitor
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446497A1 Crf receptor antagonists
11/07/2002	CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	CA2445697A1 Drug efflux pump inhibitor
11/07/2002	CA2445629A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2444334A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254660A2 Methods, kits and compositions for using pyrrole derivatives against anxiety
11/06/2002	EP1254140A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
11/06/2002	EP1254139A1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1377868A Method for reducing N oxo-compound
11/06/2002	CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093858C Quinoline and quinozoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
11/06/2002	CN1093762C Aqueous suspension of 9-hydroxyrisperidone fatty and esters
11/06/2002	CN1093759C 蛋白激酶c抑制剂 Protein kinase c inhibitor
11/05/2002	US6476226 Isoxazoline fibrinogen receptor antagonists
11/05/2002	US6476199 Reagents for lysergic acid diethylamide immunoassay
11/05/2002	US6476175 Bicyclic amidines, process for their preparation, and their use as catalyst
11/05/2002	US6476046 Diazabicyclo[4.3.0]nonanes, and methods of use thereof
11/05/2002	US6476045 Indole and azaindole derivatives and their use as tachykinin antagonists, and in particular as neurokinin-1 receptor antagonist
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476034 Antiviral azaindole derivatives
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476021 Compounds having cGMP-PDE inhibitory effect
11/05/2002	US6476019 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents

1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 646